The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding specifically to receptors or biological targets, such therapies ensure a more ...
What keeps Joseph Makowiecki excited is the recurrent need for multilayered connectivity in bioprocess development and manufacturing, particularly when it comes to new therapeutic modalities, flexible ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results